Prime Medicine (PRME) Interest & Investment Income (2023 - 2026)

Prime Medicine has reported Interest & Investment Income for 4 years, with the latest figure at $1.0 million in Q1 2026.

• For the quarter ending Q1 2026, Interest & Investment Income fell 13.62% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $4.0 million (down 0.99% YoY), and the FY2025 full-year result was $4.1 million, up 17.8% from the prior year.
• Interest & Investment Income for Q1 2026 stood at $1.0 million, down from $1.1 million in the prior quarter.
• The five-year high for Interest & Investment Income was $1.5 million in Q4 2024, with the low at $410000.0 in Q3 2023.
• Historically, Interest & Investment Income has averaged $852333.3 across 4 years, with a median of $720000.0 in 2024.
• Annual changes were most pronounced in 2024 — Interest & Investment Income surged 213.24% — and 2025, when it declined 29.58%.
• Prime Medicine's Interest & Investment Income stood at $491000.0 in 2023, then surged by 213.24% to $1.5 million in 2024, then decreased by 29.58% to $1.1 million in 2025, then fell by 5.72% to $1.0 million in 2026.
• The last three Interest & Investment Income figures came in at $1.0 million (Q1 2026), $1.1 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.